Story perspectives

mRNA Vaccines Boost Immunotherapy Efficacy in Cancer Patients

10/19/2025

22 3

Summary

Story summary

The European Society for Medical Oncology conference presented findings that mRNA Covid-19 vaccines may enhance the immune response in cancer patients treated with immune checkpoint inhibitors.
The study analyzed records from 1,000 patients with advanced lung and skin cancers and found those vaccinated within 100 days of starting immunotherapy lived nearly twice as long as unvaccinated patients.
Experts say the findings show potential synergy, but more trials are needed.

1 of 1

Story summary

The European Society for Medical Oncology conference presented findings that mRNA Covid-19 vaccines may enhance the immune response in cancer patients treated with immune checkpoint inhibitors.
The study analyzed records from 1,000 patients with advanced lung and skin cancers and found those vaccinated within 100 days of starting immunotherapy lived nearly twice as long as unvaccinated patients.
Experts say the findings show potential synergy, but more trials are needed.